During the past decade, Health First Clinical Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Health First Clinical Research Institute" #1 sponsor was "Arginox Pharmaceuticals" with 1 trials, followed by "AstraZeneca" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored and "Zealand Pharma" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Health First Clinical Research Institute" #1 collaborator was "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Health First Clinical Research Institute" are "Arthritis, Rheumatoid" (1 trials), "Cardiovascular Disease" (1 trials), "Heart Failure, Congestive" (1 trials), "Shock, Cardiogenic" (1 trials) and "Type 2 Diabetes" (1 trials). Many other conditions were trialed in "Health First Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Health First Clinical Research Institute" are "Drug" (4 trials), "Behavioral" (1 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "6-minutes walk performance" (1 trials), "Blood sampling for laboratory tests" (1 trials), "Dapagliflozin" (1 trials), "Dyspnea severity assessment" (1 trials) and "ECG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Health First Clinical Research Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Health First Clinical Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Health First Clinical Research Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Health First Clinical Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".